Multimodality Molecular Imaging Lab (MMIL)

My laboratory is developing imaging assays to monitor fundamental cellular/molecular events in living subjects including patients. Technologies such as positron emission tomography (PET), optical (fluorescence, bioluminescence, Raman), ultrasound, and photoacoustic imaging are all under active investigation.

Imaging agents for multiple modalities including small molecules, engineered proteins, and nanoparticles are under development and being clinically translated. Our goals are to detect cancer early and to better manage cancer through the use of both in vitro diagnostics and molecular imaging. Strategies are being tested in small animal models and are also being clinically translated.

Click to enlarge.
Previous years: 2017201620142012, 2011, 2010, 2009, 2008, 2006, 2005

Previous Lab Members

Sanjiv Sam Gambhir M.D., Ph.D.